Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Gonadal shield.

J A Purdy, R D Stiteler, G P Glasgow

|October 1, 1975

Summary

This summary is machine-generated.

A novel secondary gonadal shield was developed for male pelvic irradiation. This device significantly reduced the gonadal dose to 1.5-2.5% of the prescribed radiation dose.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Helical tomotherapy with simultaneous integrated boost dose painting for the treatment of synchronous primary cancers involving the head and neck.

The British journal of radiology·2014

Same author

Evaluation of hippocampus dose for patients undergoing intensity-modulated radiotherapy for nasopharyngeal carcinoma.

The British journal of radiology·2014

Same author

Clinical-dosimetric relationship between lacrimal gland dose and ocular toxicity after intensity-modulated radiotherapy for sinonasal tumours.

The British journal of radiology·2013

Same author

Intensity-modulated radiotherapy for nasopharyngeal carcinoma: improvement of the therapeutic ratio with helical tomotherapy vs segmental multileaf collimator-based techniques.

The British journal of radiology·2012

Same author

Changes in position and volume of lung cancer target volumes during stereotactic body radiotherapy (SBRT): is image guidance necessary?

Technology in cancer research & treatment·2011

Same author

Comparison of IMRT techniques in the radiotherapeutic management of head and neck cancer: is tomotherapy "better" than step-and-shoot IMRT?

Technology in cancer research & treatment·2011

Area of Science:

Medical Physics
Radiation Oncology

Background:

Pelvic irradiation in males poses a risk of gonadal exposure.
Minimizing dose to reproductive organs is crucial during radiation therapy.

Purpose of the Study:

To design and construct a secondary gonadal shield for male pelvic irradiation.
To evaluate the effectiveness of the shield in reducing gonadal dose.

Main Methods:

A secondary gonadal shield was designed and fabricated.
Utilized materials and apparatus from the Cerrobend blocking system.
Tested the shield during pelvic irradiation simulations.

Main Results:

The designed gonadal shield was successfully built.
Achieved a significant reduction in gonadal dose.

Gonadal dose was reduced to approximately 1.5 to 2.5% of the given dose.

Conclusions:

The Cerrobend-based secondary gonadal shield is effective in minimizing radiation dose to male gonads.
This shielding method offers a practical approach to gonadal protection in pelvic radiotherapy.
Further clinical validation is recommended.